EU OKs $5B Deal Joining IMS Health, Investment Funds

Law360, New York (February 3, 2010, 12:29 PM EST) -- European competition authorities have signed off on TPG Capital LP and Canada-based pension manager CPP Investment Board's $5.2 billion deal to acquire IMS Health Inc., finding that the transaction would not significantly curb competition in Europe.

The European Commission said Wednesday there are no horizontal overlaps between the activities of IMS and companies owned by the investment funds, but noted that the deal would lead to a vertical relationship between the supply of pharmaceutical market research services provided by IMS and the development and marketing of...
To view the full article, register now.